Glucagon-like Peptide-1 Receptor Agonists and Platelet Function: Potential Benefits Beyond Glycemic Control

There is cumulative evidence that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can offer cardiovascular protection extending beyond glucose-lowering and weight reduction, but the underlying mechanisms contributing to these effects remain incompletely understood. Modulation of platelet funct...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Maria Xanthopoulou, Paschalis Evangelidis, Dimitrios Poulis, Eleni Gavriilaki, Nikolaos Kotsiou, Christina Antza, Vasilios Kotsis, Chrysoula Doxani, Theodoros Mprotsis, Elias Zintzaras, Panagiota Anyfanti
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	MDPI AG 2026-03-01
Цуврал:	Pharmaceuticals
Нөхцлүүд:	atherothrombosis cardiovascular disease endothelium GLP-1 receptor agonists nitric oxide platelet activation
Онлайн хандалт:	https://www.mdpi.com/1424-8247/19/3/462
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!